Who owns SpyGlass Pharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SGP from SEC Form 13F filings across 52 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 52 institutions disclosed 26.1M shares of SpyGlass Pharma, Inc. worth $581.1M — about 78.1% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
52
13F holders
$581.1M
value, 2026 filers
78.1%
of shares outstanding (26.1M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of SGP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 8.0M | $178.6M | 1.6% | 24% | 0.0% |
| 2 | NEA Management Company, LLC | 7.4M | $164.6M | 10.4% | 22.1% | 0.0% |
| 3 | Sands Capital Alternatives, LLC | 2.5M | $55.7M | 9.1% | 7.5% | 0.0% |
| 4 | SAMSARA BIOCAPITAL, LLC | 2.1M | $47.0M | 3.9% | 6.3% | 0.0% |
| 5 | BlackRock, Inc. | 711,712 | $15.8M | 0.0% | 2.1% | +391.7% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 674,143 | $15.0M | 0.0% | 2% | -4.3% |
| 7 | Vestal Point Capital, LP | 670,000 | $14.9M | 0.3% | 2% | +0.5% |
| 8 | JPMORGAN CHASE & CO | 629,739 | $13.6M | 0.0% | 1.9% | +9.1% |
| 9 | DEERFIELD MANAGEMENT COMPANY, L.P. | 550,000 | $12.2M | 0.1% | 1.6% | 0.0% |
| 10 | MILLENNIUM MANAGEMENT LLC | 507,257 | $11.3M | 0.0% | 1.5% | +8.2% |
| 11 | Aberdeen Group plc | 493,076 | $11.0M | 0.0% | 1.5% | +123.7% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 434,423 | $9.7M | 0.0% | 1.3% | -0.1% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 277,325 | $6.2M | 0.0% | 0.8% | +119.2% |
| 14 | FRANKLIN RESOURCES INC | 233,412 | $5.2M | 0.0% | 0.7% | -22.2% |
| 15 | Affinity Asset Advisors, LLC | 131,586 | $2.9M | 0.1% | 0.4% | -47.4% |
| 16 | STATE STREET CORP | 117,561 | $2.6M | 0.0% | 0.4% | +581.5% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 85,681 | $1.9M | 0.0% | 0.3% | +43.7% |
| 18 | NORTHERN TRUST CORP | 82,451 | $1.8M | 0.0% | 0.2% | +295.2% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 75,812 | $1.7M | 0.0% | 0.2% | +1960.1% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 68,498 | $1.5M | 0.0% | 0.2% | +14.6% |
| 21 | Alyeska Investment Group, L.P. | 57,000 | $1.3M | 0.0% | 0.2% | 0.0% |
| 22 | TD Asset Management Inc | 47,580 | $1.1M | 0.0% | 0.1% | 0.0% |
| 23 | AMERIPRISE FINANCIAL INC | 45,668 | $1.0M | 0.0% | 0.1% | +2.7% |
| 24 | ALPS ADVISORS INCNEW | 33,932 | $755,326 | 0.0% | 0.1% | new |
| 25 | Bank of New York Mellon CorpNEW | 23,944 | $532,993 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.